Speaker illustration

Professor Shizuya Yamashita

Rinku General Medical Center , Izumisano (Japan)

Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on postprandial hyperlipidemia in dyslipidemic patients: a randomized cross-over study

Event: ESC Congress 2016

Topic: Drug therapy

Session: Lipid-lowering agents - New perspectives

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb